Labcorp Files 8-K on Operations and Financials

Ticker: LH · Form: 8-K · Filed: 2024-04-25T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, financial-reporting

TL;DR

Labcorp dropped an 8-K on April 25th detailing financial results and condition.

AI Summary

Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on April 25, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.

Why It Matters

This filing is a standard regulatory disclosure for Laboratory Corporation of America Holdings, informing investors and the public about the company's financial performance and operational status.

Risk Assessment

Risk Level: low — This filing is a routine regulatory disclosure and does not contain new material information that would inherently increase risk.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The provided text of the 8-K filing does not contain specific financial figures or detailed results of operations. It only indicates that the filing is for 'Results of Operations and Financial Condition'.

When was this 8-K filing submitted to the SEC?

The 8-K filing was submitted on April 25, 2024.

What is the primary purpose of this 8-K filing for Laboratory Corporation of America Holdings?

The primary purpose is to report on the company's results of operations and financial condition, and to file financial statements and exhibits as required by the SEC.

Where are Laboratory Corporation of America Holdings' principal executive offices located?

The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.

What is the SEC Act under which this 8-K is filed?

This 8-K filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0000920148-24-000029.txt : 20240425 0000920148-24-000029.hdr.sgml : 20240425 20240425070459 ACCESSION NUMBER: 0000920148-24-000029 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240425 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 24872861 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20240425.htm 8-K lh-20240425 April 25, 2024 0000920148 false 0000920148 2024-04-25 2024-04-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 25, 2024 (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact Name of Registrant as Specified in its Charter) Delaware   1-11353   13-3757370 (State or other jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 358 South Main Street   Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class            Trading Symbol            Name of exchange on which registered Common Stock , $0.10 par value          LH                  New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated April 25, 2024 issued by Labcorp titled "L

View on Read The Filing